A practical method of I-131 thyroid cancer therapy dose optimization using estimated effective renal clearance
In thyroid cancer patients with renal impairment or other complicating factors, it is important to maximize I-131 therapy efficacy while minimizing bone marrow and lung damage. We developed a web-based calculator based on a modified Benua and Leeper method to calculate the maximum I-131 dose to redu...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-12-01
|
Series: | SAGE Open Medical Case Reports |
Online Access: | https://doi.org/10.1177/2050313X17745203 |
id |
doaj-000205d7943c4d4db1bfaf1b6aff3128 |
---|---|
record_format |
Article |
spelling |
doaj-000205d7943c4d4db1bfaf1b6aff31282020-11-25T02:34:09ZengSAGE PublishingSAGE Open Medical Case Reports2050-313X2017-12-01510.1177/2050313X17745203A practical method of I-131 thyroid cancer therapy dose optimization using estimated effective renal clearanceBrandon A Howard0Olga G James1Jennifer M Perkins2Robert A Pagnanelli3Salvador Borges-Neto4Robert E Reiman5Division of Nuclear Medicine, Department of Radiology, Duke University Medical Center, Durham, NC, USADivision of Nuclear Medicine, Department of Radiology, Duke University Medical Center, Durham, NC, USADivision of Endocrinology, Department of Medicine, Duke University Medical Center, Durham, NC, USADivision of Nuclear Medicine, Department of Radiology, Duke University Medical Center, Durham, NC, USADivision of Nuclear Medicine, Department of Radiology, Duke University Medical Center, Durham, NC, USADivision of Radiation Safety, Occupational and Environmental Safety Office, Duke University, Durham, NC, USAIn thyroid cancer patients with renal impairment or other complicating factors, it is important to maximize I-131 therapy efficacy while minimizing bone marrow and lung damage. We developed a web-based calculator based on a modified Benua and Leeper method to calculate the maximum I-131 dose to reduce the risk of these toxicities, based on the effective renal clearance of I-123 as measured from two whole-body I-123 scans, performed at 0 and 24 h post-administration.https://doi.org/10.1177/2050313X17745203 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Brandon A Howard Olga G James Jennifer M Perkins Robert A Pagnanelli Salvador Borges-Neto Robert E Reiman |
spellingShingle |
Brandon A Howard Olga G James Jennifer M Perkins Robert A Pagnanelli Salvador Borges-Neto Robert E Reiman A practical method of I-131 thyroid cancer therapy dose optimization using estimated effective renal clearance SAGE Open Medical Case Reports |
author_facet |
Brandon A Howard Olga G James Jennifer M Perkins Robert A Pagnanelli Salvador Borges-Neto Robert E Reiman |
author_sort |
Brandon A Howard |
title |
A practical method of I-131 thyroid cancer therapy dose optimization using estimated effective renal clearance |
title_short |
A practical method of I-131 thyroid cancer therapy dose optimization using estimated effective renal clearance |
title_full |
A practical method of I-131 thyroid cancer therapy dose optimization using estimated effective renal clearance |
title_fullStr |
A practical method of I-131 thyroid cancer therapy dose optimization using estimated effective renal clearance |
title_full_unstemmed |
A practical method of I-131 thyroid cancer therapy dose optimization using estimated effective renal clearance |
title_sort |
practical method of i-131 thyroid cancer therapy dose optimization using estimated effective renal clearance |
publisher |
SAGE Publishing |
series |
SAGE Open Medical Case Reports |
issn |
2050-313X |
publishDate |
2017-12-01 |
description |
In thyroid cancer patients with renal impairment or other complicating factors, it is important to maximize I-131 therapy efficacy while minimizing bone marrow and lung damage. We developed a web-based calculator based on a modified Benua and Leeper method to calculate the maximum I-131 dose to reduce the risk of these toxicities, based on the effective renal clearance of I-123 as measured from two whole-body I-123 scans, performed at 0 and 24 h post-administration. |
url |
https://doi.org/10.1177/2050313X17745203 |
work_keys_str_mv |
AT brandonahoward apracticalmethodofi131thyroidcancertherapydoseoptimizationusingestimatedeffectiverenalclearance AT olgagjames apracticalmethodofi131thyroidcancertherapydoseoptimizationusingestimatedeffectiverenalclearance AT jennifermperkins apracticalmethodofi131thyroidcancertherapydoseoptimizationusingestimatedeffectiverenalclearance AT robertapagnanelli apracticalmethodofi131thyroidcancertherapydoseoptimizationusingestimatedeffectiverenalclearance AT salvadorborgesneto apracticalmethodofi131thyroidcancertherapydoseoptimizationusingestimatedeffectiverenalclearance AT robertereiman apracticalmethodofi131thyroidcancertherapydoseoptimizationusingestimatedeffectiverenalclearance AT brandonahoward practicalmethodofi131thyroidcancertherapydoseoptimizationusingestimatedeffectiverenalclearance AT olgagjames practicalmethodofi131thyroidcancertherapydoseoptimizationusingestimatedeffectiverenalclearance AT jennifermperkins practicalmethodofi131thyroidcancertherapydoseoptimizationusingestimatedeffectiverenalclearance AT robertapagnanelli practicalmethodofi131thyroidcancertherapydoseoptimizationusingestimatedeffectiverenalclearance AT salvadorborgesneto practicalmethodofi131thyroidcancertherapydoseoptimizationusingestimatedeffectiverenalclearance AT robertereiman practicalmethodofi131thyroidcancertherapydoseoptimizationusingestimatedeffectiverenalclearance |
_version_ |
1724809952191578112 |